Lineage Cell Therapeutics, Inc. (LCTX)
Lineage Cell Therapeutics, Inc. (LCTX) has a 21-report earnings history dating back to May 13, 2021. Its average absolute post-earnings move is ±3.19%, and 61.9% of those reactions were positive. Its largest post-earnings gain was +15.25% (Mar 07, 2024) and its largest decline was -4.27% (Mar 10, 2022). The next earnings report is predicted for 2026-08-10 (approximate).
Earnings reactions
How LCTX moved on each past earnings report.
Earnings Impact
Total Earnings
21
Avg Abs. Movement
±3.19%
Positive %
61.9%
Negative %
38.1%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| May 12, 2026 | ☽ POST | -3.73% | open_in_new |
| Mar 05, 2026 | ☽ POST | -1.36% | open_in_new |
| Nov 06, 2025 | ☽ POST | +1.16% | open_in_new |
| Aug 12, 2025 | ☽ POST | +2.49% | open_in_new |
Earnings Count
21
Total earnings in dataset
Avg Abs. Movement
±3.19%
Avg % price change on earnings
Institutional ownership
Holdings as of Mar 31, 2022 · SEC 13-F
SEC Filing Types
Recent SEC Filings
9 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260702 | open_in_new SEC.gov |
| 4 | 20260702 | open_in_new SEC.gov |
| 4 | 20260702 | open_in_new SEC.gov |
| 4 | 20260702 | open_in_new SEC.gov |
| 4 | 20260702 | open_in_new SEC.gov |
| 4 | 20260702 | open_in_new SEC.gov |
| 8-K | 20260612 | open_in_new SEC.gov |
| CORRESP | 20260319 | open_in_new SEC.gov |
| UPLOAD | 20260316 | open_in_new SEC.gov |
Frequently asked about LCTX earnings
When does Lineage Cell Therapeutics, Inc. report earnings next? expand_more
Lineage Cell Therapeutics, Inc. (LCTX)'s next earnings date is approximate for 2026-08-10. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does LCTX stock move after earnings? expand_more
Over 21 reports, LCTX has moved an average of ±3.19% the session after earnings, closing higher 61.9% of the time.
What was LCTX's biggest post-earnings move? expand_more
LCTX's largest post-earnings gain on record was +15.25% on Mar 07, 2024, and its largest decline was -4.27% on Mar 10, 2022.
Where can I find Lineage Cell Therapeutics, Inc.'s SEC filings? expand_more
All of Lineage Cell Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right
Reporting around the same time
- ALICO, INC. (ALCO) earnings 2026-08-07
- ASCENT INDUSTRIES CO. (ACNT) earnings 2026-08-07
- Aclaris Therapeutics, Inc. (ACRS) earnings 2026-08-07
- ACV Auctions Inc. (ACVA) earnings 2026-08-07
- ADC Therapeutics SA (ADCT) earnings 2026-08-07
- ADMA BIOLOGICS, INC. (ADMA) earnings 2026-08-07
- Aeva Technologies, Inc. (AEVA) earnings 2026-08-07
- Agenus Inc. Common Stock (AGEN) earnings 2026-08-07